News | Stroke
Patients who have had a stroke in the back of the brain are at greater risk of having another within two years if blood flow to the region is diminished, according to results of a multicenter study led by researchers at the University of Illinois at Chicago (UIC).
December 23, 2015
Feature | Genetic Testing | Kevin P. Greene, M.D.
Statins are lifesaving medications — they have been shown to greatly reduce heart attack and other related events by ...
December 22, 2015News | Point of Care Testing
Trinity Biotech plc announced submission of its Meritas Point of Care Analyzer and Meritas cardiac troponin-I (cTnI) point-of-care assay for U.S. Food and Drug Administration (FDA) 510(k) clearance.
December 22, 2015Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology | Sudden Cardiac Arrest
December 22, 2015 - The U.S. Food and Drug Administration has cleared the Zoll LifeVest Wearable Cardioverter ...
December 22, 2015
Technology | Clinical Decision Support
December 22, 2015 — The American College of Cardiology (ACC) has launched a new Society of Thoracic Surgeons (STS)/ACC ...
December 22, 2015
Technology | Analytics Software
At the 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Siemens displayed new offerings for teamplay, a cloud-based network that helps link hospitals and healthcare experts, enabling them to exchange data and pool their knowledge.
December 22, 2015Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | ACC
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors ...
December 22, 2015Technology | Implantable Cardioverter Defibrillator (ICD)
December 22, 2015 — Biotronik received U.S. Food and Drug Administration (FDA) approval for use of its latest family of ...
December 22, 2015
Technology | Advanced Visualization
Siemens Healthcare’s approach to delivering dose-neutral dual energy images obtained on Somatom computed tomography (CT) scanners using TwinBeam Dual Energy technology is now commercially available on the Somatom Definition Edge and Somatom Definition AS CT systems.
December 21, 2015Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology | Patient Engagement
Carestream Health showcased its MyVue Center Self-Service Kiosk that enhances patient access and sharing of their medical exam records at the 2015 Radiological Society of North America (RSNA) conference.
December 21, 2015
Technology | Magnetic Resonance Imaging (MRI)
Philips Healthcare introduced ScanWise Implant, the industry’s first magnetic resonance imaging (MRI)-guided user interface and automatic scan parameter selection, at the 2015 Radiological Society of North America (RSNA) annual meeting.
December 21, 2015
Technology | PACS Accessories
GE Healthcare showed its latest software solutions for data analytics and dose monitoring at the 2015 Radiological Society of North America (RSNA) annual meeting, Nov. 29-Dec. 3 in Chicago.
December 17, 2015Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Population Health
Valentin Fuster, M.D., Ph.D., director of Mount Sinai Heart and physician-in-chief of The Mount Sinai Hospital, joined a panel of international experts at the United Nations where he spoke about promoting cardiovascular health worldwide and how the practice of medicine will change to reflect an increase in ambulatory care.
December 17, 2015
The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III trial (ROCKET AF) of the oral anticoagulant rivaroxaban. The analysis was prompted by a December 2014 U.S. Food and Drug Administration (FDA) recall of a device used in the study.
December 17, 2015News | Embolization devices
ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS Gen II). The EOS is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.
December 17, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now